Questions surround insider trading probe around Amgen bid for Onyx

You are here: Home > Columns > Current Article

Questions surround insider trading probe around Amgen bid for Onyx

By Henry Dubroff / Friday, July 12th, 2013 / Comments Off on Questions surround insider trading probe around Amgen bid for Onyx

Less than a week after Onyx spurned Amgen’s takeover bid, the SEC went to court and froze some $4.3 million in accounts in the Canary Islands and Beirut.

This article is only available to Business Times subscribers

Subscribers: LOG IN or REGISTER for complete digital access.
Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists.
Check the STATUS of your Subscription Account.